Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft — For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn't isolate its active ingredient until the 1800s
Posted from: this blog via Microsoft Power Automate.
